Alps Advisors Inc Imago Bio Sciences, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.03 - $35.96 $68,476 - $163,833	4,556 Added 24.8%	22,929 $824,000
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $23,206 - $31,980	-1,640 Reduced 8.19%	18,373 $277,000
Q2 2022 Aug 11, 2022	SELL	$11.81 - $20.92 $170,619 - $302,231	-14,447 Reduced 41.92%	20,013 $268,000
Q1 2022 May 16, 2022	SELL	$16.97 - $25.0 $73,683 - $108,550	-4,342 Reduced 11.19%	34,460 $664,000
Q4 2021 Feb 09, 2022	BUY	$16.22 - $29.69 $629,368 - $1.15 Million	38,802 New	38,802 $920,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.